159 related articles for article (PubMed ID: 22414228)
1. KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients.
Dai XP; Huang Q; Yin JY; Guo Y; Gong ZC; Lei MX; Jiang TJ; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2012 May; 39(5):462-8. PubMed ID: 22414228
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes.
Li Q; Tang TT; Jiang F; Zhang R; Chen M; Yin J; Bao YQ; Cheng X; Hu C; Jia WP
Acta Pharmacol Sin; 2017 Jan; 38(1):80-89. PubMed ID: 27694910
[TBL] [Abstract][Full Text] [Related]
3. Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus.
Wang T; Wang Y; Lv DM; Song JF; Lu Q; Gao X; Zhang F; Guo H; Li W; Yin XX
Pharmacotherapy; 2014 Feb; 34(2):131-9. PubMed ID: 24338736
[TBL] [Abstract][Full Text] [Related]
4. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
Huang Q; Yin JY; Dai XP; Pei Q; Dong M; Zhou ZG; Huang X; Yu M; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2010 Jun; 31(6):709-17. PubMed ID: 20523342
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the polymorphisms in KCNQ1 and type 2 diabetes in Chinese Kazakh population.
Cui LJ; Chang XY; Zhu LY; Feng G; Zhou T; Zhang CX; Chong KY; Sun K
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323013
[TBL] [Abstract][Full Text] [Related]
6. Effects of KCNQ1 polymorphisms on the therapeutic efficacy of oral antidiabetic drugs in Chinese patients with type 2 diabetes.
Yu W; Hu C; Zhang R; Wang C; Qin W; Lu J; Jiang F; Tang S; Bao Y; Xiang K; Jia W
Clin Pharmacol Ther; 2011 Mar; 89(3):437-42. PubMed ID: 21289621
[TBL] [Abstract][Full Text] [Related]
7. KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes.
Yu M; Xu XJ; Yin JY; Wu J; Chen X; Gong ZC; Ren HY; Huang Q; Sheng FF; Zhou HH; Liu ZQ
Clin Pharmacol Ther; 2010 Mar; 87(3):330-5. PubMed ID: 20054294
[TBL] [Abstract][Full Text] [Related]
8. A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients.
Zhou X; Zhu J; Bao Z; Shang Z; Wang T; Song J; Sun J; Li W; Adelusi TI; Wang Y; Lv D; Lu Q; Yin X
Sci Rep; 2016 Nov; 6():37293. PubMed ID: 27857189
[TBL] [Abstract][Full Text] [Related]
9. NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus.
Sheng FF; Dai XP; Qu J; Lei GH; Lu HB; Wu J; Xu XJ; Pei Q; Dong M; Liu YZ; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):550-4. PubMed ID: 21631570
[TBL] [Abstract][Full Text] [Related]
10. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
Huang Q; Yin JY; Dai XP; Wu J; Chen X; Deng CS; Yu M; Gong ZC; Zhou HH; Liu ZQ
Eur J Clin Pharmacol; 2010 Dec; 66(12):1207-15. PubMed ID: 20809084
[TBL] [Abstract][Full Text] [Related]
11. KCNQ1 gene polymorphisms are associated with lipid parameters in a Chinese Han population.
Chen Z; Yin Q; Ma G; Qian Q
Cardiovasc Diabetol; 2010 Aug; 9():35. PubMed ID: 20701788
[TBL] [Abstract][Full Text] [Related]
12. A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients.
Zhou X; Chen C; Yin D; Zhao F; Bao Z; Zhao Y; Wang X; Li W; Wang T; Jin Y; Lv D; Lu Q; Yin X
Intern Med; 2019 Aug; 58(16):2341-2347. PubMed ID: 31118371
[TBL] [Abstract][Full Text] [Related]
13. NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
Gong ZC; Huang Q; Dai XP; Lei GH; Lu HB; Yin JY; Xu XJ; Qu J; Pei Q; Dong M; Zhou BT; Shen J; Zhou G; Zhou HH; Liu ZQ
Br J Clin Pharmacol; 2012 Sep; 74(3):501-9. PubMed ID: 22296034
[TBL] [Abstract][Full Text] [Related]
14. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
Song JF; Wang T; Zhu J; Zhou XY; Lu Q; Guo H; Zhang F; Wang Y; Li W; Wang DD; Cui YW; Lv DM; Yin XX
Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380
[TBL] [Abstract][Full Text] [Related]
15. A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus.
Shang Z; Han F; Zhou X; Bao Z; Zhu J; Wang T; Lu Q; Du L; Li W; Lv D; Yin X
Drug Dev Res; 2018 May; 79(3):129-135. PubMed ID: 29663513
[TBL] [Abstract][Full Text] [Related]
16. Association study of four variants in KCNQ1 with type 2 diabetes mellitus and premature coronary artery disease in a Chinese population.
Chen Z; Zhang X; Ma G; Qian Q; Yao Y
Mol Biol Rep; 2010 Jan; 37(1):207-12. PubMed ID: 19575309
[TBL] [Abstract][Full Text] [Related]
17. Associations of
Yu XX; Liao MQ; Zeng YF; Gao XP; Liu YH; Sun W; Zhu S; Zeng FF; Ye YB
J Diabetes Res; 2020; 2020():7145139. PubMed ID: 32695830
[TBL] [Abstract][Full Text] [Related]
18. Identifying the association between single nucleotide polymorphisms in
Li Y; Shen K; Li C; Yang Y; Yang M; Tao W; He S; Shi L; Yao Y
Int J Med Sci; 2020; 17(15):2379-2386. PubMed ID: 32922204
[No Abstract] [Full Text] [Related]
19. KCNQ1 haplotypes associate with type 2 diabetes in Malaysian Chinese Subjects.
Saif-Ali R; Ismail IS; Al-Hamodi Z; Al-Mekhlafi HM; Siang LC; Alabsi AM; Muniandy S
Int J Mol Sci; 2011; 12(9):5705-18. PubMed ID: 22016621
[TBL] [Abstract][Full Text] [Related]
20. Effect of genetic polymorphism of UCP2-866 G/A on repaglinide response in Chinese patients with type 2 diabetes.
Wang S; Se YM; Liu ZQ; Lei MX; Hao-BoYang ; Sun ZX; Nie SD; Zeng XM; Wu J
Pharmazie; 2012 Jan; 67(1):74-9. PubMed ID: 22393835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
